Literature DB >> 26496515

Iminothiazoline-Sulfonamide Hybrids as Jack Bean Urease Inhibitors; Synthesis, Kinetic Mechanism and Computational Molecular Modeling.

Aamer Saeed1, Shams-Ul Mahmood1, Muhammad Rafiq2, Zaman Ashraf2,3, Farukh Jabeen4,5, Sung-Yum Seo2.   

Abstract

The present work reports the synthesis of several 2-iminothiazoline derivatives of sulfanilamide (3a-j) as inhibitors of jack bean ureases. The title compounds were synthesized by the heterocyclization of sulfanilamide thioureas with propragyl bromide in dry ethanol in the presence of 1,8-Diazabicyclo[5.4.0]undec-7-ene as a base. All of the compounds showed higher urease inhibitory activity than the standard thiourea. The compounds (3h) and (3i) exhibited excellent enzyme inhibitory activity with IC50 0.064 and 0.058 μm, respectively, while IC50 of thiourea is 20.9 μm. The kinetic mechanism analyzed by Dixon plot showed that compound (3h) is a mixed-type inhibitor while (3i) is a competitive one. Docking studies suggested that Asp633, Ala636, His492, Ala440, Lue523, Asp494 and Arg439 are the major interacting residues in the binding site of the protein and may have an instrumental role in the inhibition of enzyme's function. 2-iminothiazoline analogues (3a-j) showed good docking score (-10.6466 to -8.7215 Kcal/mol) and binding energy (London dG ranging from -14.4825 to -10.4087 Kcal/mol) which is far better than the standard thiourea (binding score in S field -4.5790 Kcal/mol London dG -4.7726 Kcal/mol). Our results inferred compound (3i) may serve as a structural model for the design of most potent urease inhibitors.
© 2015 John Wiley & Sons A/S.

Entities:  

Keywords:  iminothiazoline-sulfonamides; kinetic mechanism; molecular modeling; urease inhibitors

Mesh:

Substances:

Year:  2015        PMID: 26496515     DOI: 10.1111/cbdd.12675

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  6 in total

1.  Synthesis of chiral pyrazolo[4,3-e][1,2,4]triazine sulfonamides with tyrosinase and urease inhibitory activity.

Authors:  Mariusz Mojzych; Paweł Tarasiuk; Katarzyna Kotwica-Mojzych; Muhammad Rafiq; Sung-Yum Seo; Michał Nicewicz; Emilia Fornal
Journal:  J Enzyme Inhib Med Chem       Date:  2016-10-25       Impact factor: 5.051

2.  Sulfonamide-Linked Ciprofloxacin, Sulfadiazine and Amantadine Derivatives as a Novel Class of Inhibitors of Jack Bean Urease; Synthesis, Kinetic Mechanism and Molecular Docking.

Authors:  Pervaiz Ali Channar; Aamer Saeed; Fernando Albericio; Fayaz Ali Larik; Qamar Abbas; Mubashir Hassan; Hussain Raza; Sung-Yum Seo
Journal:  Molecules       Date:  2017-08-16       Impact factor: 4.411

Review 3.  Recent advances in design of new urease inhibitors: A review.

Authors:  Paweł Kafarski; Michał Talma
Journal:  J Adv Res       Date:  2018-01-31       Impact factor: 10.479

4.  Enzyme Inhibitory Kinetics and Molecular Docking Studies of Halo-Substituted Mixed Ester/Amide-Based Derivatives as Jack Bean Urease Inhibitors.

Authors:  Muhammad Rashid; Hummera Rafique; Sadia Roshan; Shazia Shamas; Zafar Iqbal; Zaman Ashraf; Qamar Abbas; Mubashir Hassan; Zia Ur Rahman Qureshi; Muhammad Hassham Hassan Bin Asad
Journal:  Biomed Res Int       Date:  2020-12-24       Impact factor: 3.411

5.  Exploring Amantadine Derivatives as Urease Inhibitors: Molecular Docking and Structure-Activity Relationship (SAR) Studies.

Authors:  Atteeque Ahmed; Aamer Saeed; Omar M Ali; Zeinhom M El-Bahy; Pervaiz Ali Channar; Asma Khurshid; Arfa Tehzeeb; Zaman Ashraf; Hussain Raza; Anwar Ul-Hamid; Mubashir Hassan
Journal:  Molecules       Date:  2021-11-25       Impact factor: 4.411

6.  Novel essential amino acid-sulfanilamide hybrid as safe anti-ulcerogenic agent with anti-helicobacter pylori activity.

Authors:  Amani S Awaad; Ahmed M Alafeefy; Fatmah A S Alasmary; Reham M El-Meligy; M E Zain; Saleh I Alqasoumi
Journal:  Saudi Pharm J       Date:  2017-02-27       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.